Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 168   

Articles published

GSK 1,465.94
price chart
3 Blue-Chip Marvels Trading At Unmissable Prices: GlaxoSmithKline plc ...
The problem of serious patent losses continues to stunt investor appetite for pharma plays such as GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Shares in the firm have steadily declined in recent weeks and have shed more than 10% since mid-April, but I ...
Analytic Report on GlaxoSmithKline PLC (ADR) (NYSE:GSK)  Street Report
Pre Movers- ANN INC. (NYSE:ANN), GlaxoSmithKline plc (NYSE:GSK), HSBC ...  StreetWise Report
Gilead Sciences, Inc., GlaxoSmithKline plc, Johnson & Johnson Looking To Gain ...
The approved HIV drugs used in the trial were supplied by AbbVie Inc (NYSE:ABBV), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences, Inc. (NASDAQ:GILD), GlaxoSmithKline plc (ADR) (NYSE:GSK), Janssen Scientific Affairs of Johnson and Johnson ...
Recent Analysts' Ratings Updates for GlaxoSmithKline plc (GSK)
5/28/2015 - GlaxoSmithKline plc had its “market perform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a GBX 1,410 ($21.82) price target on the stock.
Sanford C. Bernstein Reiterates "Market Perform" Rating for ...  sleekmoney
JPMorgan Chase & Co. Reaffirms "Underweight" Rating for ...  Mideast Time
As Bioquell plc Surges, Should You Dump It To Invest In GlaxoSmithKline plc?
Bioquell (LSE: BQE) announced today that it was looking for partners - inevitably, the stock rose more than 8% on the day, after an already impressive rally (+45%) so far this year.
What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Royal ...
Top FTSE 100 pharmaceuticals firm GlaxoSmithKline still does blockbuster drugs, but Merchants likes the way the company has been consolidating its global leadership positions in vaccines and consumer health, where there are “scale advantages” and ...
Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or ...
GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) are similar businesses, but if you could only pick one then choosing between the two is difficult.
3 Shares With Terrific Growth Prospects: GlaxoSmithKline plc, Unilever plc And ...
It is true that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) - like much of the pharmaceuticals sector - could be considered a risky pick for those seeking copper-bottomed growth prospects.
GlaxoSmithKline plc Pleases The Market With New Strategic 5-Year Plan
GlaxoSmithKline (LSE: GSK) released its results for the first quarter today and the company also issued a strategic update.
Does GlaxoSmithKline plc's Latest Treatment Point To Its Future?  Yahoo Finance UK
GlaxoSmithKline plc 19.1% Potential Upside Indicated by Barclays Capital  DirectorsTalk Interviews
Beat A Volatile FTSE 100 With GlaxoSmithKline plc, Smith & Nephew plc, WPP ...
While the FTSE 100 gained a boost from the Conservative election victory, its medium-term outlook may be somewhat uncertain. That's because, while the UK economy is performing well, the EU referendum could take place next year and, between now and ...
Brokerages Set GlaxoSmithKline plc Price Target at $52.00 (NYSE:GSK)  sleekmoney
GlaxoSmithKline PLC Price Target Update  The Daily Rover
Here's Why GlaxoSmithKline plc Is Set To Outperform Unilever plc & Diageo PLC
“On 6 May we attended the consumer part of GSK's investor event, hosted by Emma Walmesley, CEO of GSK Consumer Healthcare,” analysts at Royal Bank of Canada wrote in research published today, adding that “in many respects it was just like any other ...
Why GlaxoSmithKline plc And Imperial Tobacco Group PLC Are Perfect Partners ...  Yahoo Finance UK